All posts by imreal

Palette Life Sciences Launches the Deflux Learning Center, a New Online Resource to Support Healthcare Professionals Who Treat Vesicoureteral Reflux (VUR)


News Image

As a physician, I’m delighted about this new resource center, which provides valuable information, education and training on VUR and Deflux. – Dr. Christopher Cooper, Board-Certified Pediatric Urologist of the University of Iowa Stead Family Children’s Hospital

Palette Life Sciences, Inc., a fully integrated life sciences company dedicated to improving patient outcomes, today announces the launch of the Deflux Learning Center, a valuable new online resource to support pediatric urologists who treat vesicoureteral reflux (VUR). The Deflux Learning Center contains comprehensive VUR and Deflux-related information, education, training, tools and resources to help pediatric urologists and pediatricians learn more about VUR and treatment options and provide them with educational materials for referring physicians, administrators and caregivers.

The Deflux Learning Center features:


  • The PedSpace – a new podcast series sponsored by Palette Life Sciences, featuring physicians discussing pediatric urology, VUR and Deflux, as well as broader topics, like telemedicine and more.
  • Educational videos and webinars – including Deflux training videos and webinars on how and when to use Deflux, the injection technique, and content for pediatric urologists to download and share with referring physicians regarding diagnosing and grading VUR.
  • Clinical articles – containing important scientific information pertaining to diagnosing, grading and treating VUR.
  • Brochures and downloadable resources and tools – including physician and caregiver resources, product instructions for use, reimbursement information, and more.
  • Events Calendar – featuring information about upcoming conferences, trainings and other industry events and meetings for physicians.

“As a physician, I’m delighted about this new resource center, which provides valuable information, education and training on VUR and Deflux,” said Dr. Christopher Cooper, Board-Certified Pediatric Urologist of University of Iowa Stead Family Children’s Hospital.

“At Palette Life Sciences, we are delighted to support pediatric urologists and their work to improve patient outcomes. Through the new Deflux Learning Center, we have provided a wide variety of resources that are accessible from anywhere and will greatly help them treat VUR by engaging in new educational content,” said Rich Low, Head of Marketing.

About VUR

Vesicoureteral reflux (VUR), sometimes referred to as urinary or bladder reflux, is a serious pediatric urinary condition in which urine refluxes from the bladder through one or both ureters toward the kidneys. This is due to an abnormality in the region where the ureter meets the bladder. Normally, a valve at the entrance to the bladder prevents backward flow of urine. Infected urine can reflux back into the ureters and, in severe cases, into the kidneys – which may lead to long-term kidney damage. Deflux is a minimally invasive, outpatient procedure that has been proven safe and effective in children with VUR grades II-IV. Deflux is a gel made from two tissue-friendly polysaccharides (types of sugars) – Non-Animal Stabilized Hyaluronic Acid (NASHA®) and dextranomer (Dx) – and is used as a tissue bulking agent that is injected around the ureteral opening to prevent urine from flowing back up from the bladder through the ureters.

About Deflux

Deflux is a minimally invasive, outpatient procedure that has been proven safe and effective in children with VUR. Deflux is a gel made from two tissue-friendly polysaccharides (types of sugars) – hyaluronic acid (HA) and dextranomer (Dx) – and is used as a tissue bulking agent that is injected inside the ureteral opening to prevent urine from flowing back up from the bladder through the ureters. Learn more at Deflux.com.

About Palette Life Sciences AB

Palette Life Sciences is a fully integrated life sciences company. Palette’s products improve patient outcomes in urology and urogynecology disorders, colorectal conditions, radiotherapy, and interventional oncology procedures. The Company’s portfolio of available products includes Deflux®, Solesta® and Barrigel®. Palette Life Sciences moves rapidly to leverage novel applications of existing technologies to create breakthrough medical solutions. This focus enables the company to serve those often overlooked by traditional medical companies and improve patient quality of life. Led by experienced healthcare executives, Palette Life Sciences is headquartered in Stockholm, Sweden, with offices in Santa Barbara, California, and Dallas, Texas. Learn more at http://www.palettelifesciences.com.

© 2020 Palette Life Sciences, Inc. All rights reserved.

Deflux® and NASHA® are registered trademarks. APM203A

Share article on social media or email:

AHN Selects Chong S. Park, MD, FACS, to Lead Jefferson and Canonsburg Hospitals


AHN Selects Chong S. Park, MD, FACS, to Lead Jefferson and Canonsburg Hospitals

“Both Jefferson and Canonsburg Hospital are vital community resources, and I am excited about the opportunity to help further advance their broader missions in this new leadership role,” said Dr. Park.

Allegheny Health Network (AHN) today announced the appointment of Chong S. Park, MD, FACS, as President of Jefferson Hospital and Canonsburg Hospital.

He will assume the new role effective immediately, succeeding Louise Urban, who was appointed as Senior Vice President of Operations for AHN in May.

Dr. Park is a long-time AHN cardiothoracic surgeon, and served as Medical Director of the Cardiovascular Institute at Jefferson. For the past six years, he has also served as Jefferson’s Chief Medical Officer, leading the hospital’s medical staff and clinical operations, ensuring the highest standards of patients care quality and safety at the hospital and its affiliated facilities across the south hills region.

Dr. Park has been a key member of the clinical leadership team at Jefferson Hospital over the last decade, and has played an important role in the hospital’s success since its 2013 affiliation with Allegheny Health Network.

Under his leadership, the quality of Jefferson’s cardiac program and medical services overall has received numerous accreditations and honors, including the most recent A grade for safety by the Leapfrog group.

Jefferson Hospital also was the first healthcare facility in Western Pennsylvania to earn the American Heart Association’s Mission: Lifeline® Heart Attack Receiving Center accreditation. The hospital’s Cardiac Surgical Program also achieved a three-star rating, the highest possible grade, from the Society of Thoracic Surgeons for its excellence in caring for its complex cardiac surgical patients.

“For many years, I have been privileged to part of an extraordinary culture of caring and compassion at Jefferson Hospital that makes a difference every day in the health and well-being of the patients and communities we serve,” Dr. Park said. “Both Jefferson and Canonsburg Hospital are vital community resources, and I am excited about the opportunity to help further advance their broader missions in this new leadership role.”

Jefferson is a 341-bed tertiary care hospital located in Jefferson Hills, Pa.; Canonsburg is a 104-bed community hospital located in Canonsburg, Pa.

As part of its transformation since affiliating with AHN in 2014, Jefferson has opened a new cancer center, a new obstetrical program and a newly expanded, state-of-the-art emergency department, among other significant capital and programmatic investments. Canonsburg too has added programs in recent years, including cardiovascular and pulmonary rehabilitation programs and an advanced women’s imaging center, among other services.

Both Canonsburg and Jefferson also recently enhanced their critical care capacity through a unique partnership with St. Louis-based Mercy Virtual.

Dr. Park lives in Upper St. Clair and is a life-long South Hills resident. He comes from a family of doctors – his father was a prominent heart surgeon in the greater Pittsburgh region, his mother was a radiologist, his brother is a heart surgeon and his sister is a neonatologist.

Cynthia Hundorfean, president and Chief Executive Officer of AHN, said Dr. Park’s depth of experience as a clinical leader and his familiarity with the health care needs of the South Hills region makes him uniquely qualified to lead Jefferson and Canonsburg.

“Our network has taken tremendous strides over the last several years in establishing itself as a high-quality, patient-centered provider of choice in Western Pennsylvania,” she said. “The leadership of clinicians like Dr. Park has been fundamental to that success. He is an exceptionally talented surgeon and physician executive, and we look forward to the leadership he will bring to this critical role for our organization.”

Dr. Park becomes the sixth physician president currently leading an AHN hospital, joining Vicenta Gaspar-Yoo, MD (Allegheny Valley Hospital); Christopher Clark, DO (Saint Vincent Hospital); Mark Rubino, MD (Forbes Hospital), and David Parda, MD (Allegheny General Hospital). Allan Klapper, MD, has also been appointed as president of AHN’s Wexford Hospital, which is slated to open in the fall of 2021. Nurse executive Ron Andro is president of West Penn Hospital.

Dr. Park earned his medical degree from Hahnemann University School of Medicine in Philadelphia and completed his post-graduate residencies at Allegheny General Hospital (cardiothoracic surgery) and Brown University (general surgery).

His professional affiliations include memberships in the Allegheny County Medical Society, the Pennsylvania Medical Society, and the Pennsylvania Association for Thoracic Surgery. He also is a fellow of both the American College of Surgeons and the Society of Thoracic Surgeons.

Dr. Park also will continue his clinical practice at Jefferson Hospital in addition to assuming the President role.

###

About the Allegheny Health Network:

Allegheny Health Network (AHN.org), a Highmark Health company, is an integrated healthcare delivery system serving the greater Western Pennsylvania region. The Network is composed of 12 hospitals, ambulatory surgery centers, Health + Wellness Pavilions, an employed physician organization, home and community-based health services, a research institute, and a group purchasing organization. The Network provides patients with access to a complete spectrum of advanced medical services, including nationally recognized programs for primary and emergency care, trauma care, cardiovascular disease, organ transplantation, cancer care, orthopedic surgery, neurology and neurosurgery, women’s health, diabetes, autoimmune disease and more. AHN employs approximately 21,000 people, has more than 2,500 physicians on its medical staff and serves as a clinical campus for Drexel University College of Medicine, Temple University School of Medicine, and the Lake Erie College of Osteopathic Medicine.

How To Compare Car Insurance Quotes And Find Affordable Coverage


News Image

“Using online car insurance quotes, the right way, will help drivers find policies suitable for their needs and budget”, said Russell Rabichev, Marketing Director of Internet Marketing Company.

Compare-autoinsurance.org (https://compare-autoinsurance.org/) launched a new blog post that explains more about how to compare car insurance quotes online and find the most suitable offers.

For more info and free car insurance quotes online, visit https://compare-autoinsurance.org/how-to-compare-car-insurance-quotes-2/

Nowadays it is really easy to find car insurance quotes online and check prices. The difficult part is how to correctly evaluate and compare prices from multiple insurance providers. That makes the difference between an advantageous policy and a bad one.

To compare different car insurance quotes and to find the best insurance plan, drivers should follow the next tips:

  • Compare car insurance quotes online for free. Drivers can simply enter their ZIP code on a brokerage website and check the offers made by providers that sell policies in their areas. Sometimes, drivers will see a general price range for car insurance policies in their areas. At the very least, they can see the names of companies offering auto insurance in their region.
  • Request customized quote forms from multiple insurers. To get a more accurate idea of which insurance provider is the best, drivers should complete several quote forms from different insurers. In these forms, customers will have to submit their personal information such as age, gender, driving record, and other information.
  • Verify coverage conditions and compare identical insurance plans. Different car insurance companies have different standard policies. While some insurers will display their basic liability insurance by default, other providers might show the price for full coverage car insurance, which includes liability, collision, and comprehensive coverage. Also, car insurance plans can vary based on coverage limits.
  • Check J.D. Power ratings. Every year, J.D. Power publishes two studies. The first study is the U.S. Auto Claims Satisfaction Study, where they reveal how easily were customers able to process an insurance claim and if the policyholders were satisfied with the claims process overall. The second study, Insurance Shopping Study, reveals how competitive were the insurance company’s prices and how easy was the shopping experience for customers. It’s not uncommon for certain companies to consistently rank better than their competitors in terms of claims satisfaction and insurance shopping.
  • Check out the complaints about each insurance provider. Drivers can do that by checking The Association of Insurance Commissioners (NAIC) site. The NAIC offers two types of complaint reports. First is the Closed Complaint Counts by Code, where drivers can find out the reasons why complaints were filed against a particular car insurance company. The second is the Closed Complaint Ratio Report, where policyholders can see the number of complaints adjusted by market share. When looking at complaints, drivers can find various information such as reasons for complaint, complaints by type of insurance, a description of what happened, denial of the claim, charging extra fees, and more.
  • Look for discounts that are unique to each provider. Some providers offer discounts exclusive to that company. For example, some insurers are specialized in insuring high-risk drivers and they can offer better rates for these drivers than most insurers. Other discounts that may be unique at one provider include complimentary rental car insurance coverage, discounts to active duty or retired military personnel and their families, discounts for police officers, nurses, doctors, teachers, and more.

For additional info, money-saving tips and free car insurance quotes, visit https://compare-autoinsurance.org/

Compare-autoinsurance.org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc.

Share article on social media or email:

Sunbelt Health Partners Teams Up with Flywire to Provide Patients with Seamless End-to-End Payment Solution


Sunbelt Health Partners, an expert in increasing revenue for hospitals and specialty physician practices from international healthcare accounts receivables, announced today its partnership with Flywire, a high-growth vertical payments company.

The partnership will enable Sunbelt Health Partners to seamlessly deliver an end-to-end patient payment experience, focusing on the pre-bill registration experience. It offers convenience, transparency, and control for patients while modernizing, enabling, and securing the international and domestic payment process. With the partnership, Sunbelt HP’s Pre-Bill Patient solution deployed during registration, proactively collects the patients’ accurate billing information, captures communication preferences and seamlessly connects the patient to the Flywire payment portal to offer secure payment options and personalized payment plans.

“We are in unprecedented times with the global COVID-19 pandemic. Now more than ever, it is imperative for patients to have the ability to register their payment information before their health visits, to better comply with our new social distancing practices,” said Matt Vines, executive vice president, Sunbelt Health Partners. “Our partnership with Flywire comes at the perfect time to help simplify and streamline healthcare billing operations, giving hospitals and practices the ability to capture payments faster and reduce denials without sacrificing the patient payment experience. Patients receive the flexibility and clarity they need and deserve, and providers gain greater transparency into costs.”

“The partnership between Sunbelt Health Partners and Flywire meets both patient and provider demand for a more personalized, responsive payment experience,” said John Talaga, EVP and GM of Flywire’s healthcare business. “Since the outset of the COVID-19 pandemic, Flywire has been adapting quickly to provide new solutions that ease the financial burden on patients and decrease bad debt for health systems, such as lower-installment payment plans and COVID-19 relief payments. We know that we have a great partner in Sunbelt Health and are looking forward to ongoing collaboration to improve patient engagement and affordability.”

About Sunbelt Health Partners

Sunbelt Health Partners leverages 30+ years of complex international healthcare claims experience and international payer relationships to help hospitals, specialty physician practices, and RCM companies quickly resolve and recover international emergent patient claims. More than 100+ hospitals and specialty physician practices trust Sunbelt Health Partners to navigate and negotiate complex and emergent patient claims, including self-pay balances, international and travel insurance accounts. Trust the global accounts receivables experts. Find us here: http://www.sunbelthealthpartners.com. Follow us: Twitter, LinkedIn.

About Flywire

Flywire is a high-growth vertical payments company trusted by organizations around the world to deliver on their customers’ most important moments. Unlike other companies, Flywire is proven to solve vertical-specific payment and receivables problems for organizations that deliver high-value services. Whether in education, healthcare, travel, or technology, Flywire has vertical-specific insight and technology that allows organizations to optimize the payment experience for their customers while eliminating operational challenges. To date, Flywire has processed over $16 billion in total payments volume for over 2,000 clients around the world. The company is headquartered in Boston, MA, USA, and has offices around the world. For more information, visit http://www.flywire.com. Follow Flywire on Twitter, LinkedIn, and Facebook.

Share article on social media or email:



Dr. James Wright II, Ph.D. Awarded Grant from Florida State University to Study Why People of Color are Particularly Vulnerable to COVID-19


One size fits all may work for a facemask these days, but James E. Wright II, Ph.D. is working to prove a similar, universal program does not work as an overall response to the virus causing the need for the PPE.

The coronavirus COVID-19 has affected nearly everyone’s daily life in one way or another, from plummeting stock markets and rising unemployment on a macro scale to social distancing to closed parks in your own neighborhood. Some communities have implemented curfews while some states have put mandatory stay-at-home orders into place.

“Resources are being distributed to fight COVID-19 on a massive scale, but the data shows marginalized and underrepresented peoples – people of color, native peoples, the elderly, low-income people – are particularly vulnerable,” said Wright, an assistant professor at the Askew School of Public Administration and Policy. “We have been analyzing early data from several Florida counties and the initial results are startling. In Leon County, the state-reported number of diagnosed cases of African Americans and whites with COVID-19 is nearly equal, but there are twice as many whites living in the county. I’m convinced this is not a one-size-fits-all situation.”

To establish a stronger baseline, Wright is collecting and analyzing information from all 67 Florida counties as part of a grant-funded from Florida State University. The dataset and analysis will be completed by August 2020. The information includes how many tests have been administered, who has tested positive for the virus, who is hospitalized, and how many people have died from complications of the virus. The medical data will be combined with demographic and economic data from the county level in an effort to understand how economic and racial disparities may affect populations at the local level as well as Florida Department of Health data with American Community Survey data.

“This dataset will be able to track COVID-19 data at the county level,” Wright said. “That can be much more local and much more responsive than a state-level or national-level project. When you match the COVID-19 data up against demographic indicators and economic information, you can develop tools to more efficiently distribute financial and medical resources to help alleviate any inequities in these areas. To put it bluntly, you have a better chance of getting the right resources where they will do the most good.

“The data will give us a localized look at how communities in Florida are handling COVID-19,” Wright continued. “The end result should allow specific counties and local communities to base their policy decisions on data specific to their communities and their needs. Florida, or California or New York, is not a single, monolithic community. The needs of Cape Canaveral are going to be different than Key West. Local data can help local leaders help their community.”

Wright’s team is also working on drafting a policy brief to address the specific social and economic impacts of COVID-19, again based on the local dataset.

“The model could then be used by any state to examine the same local data for the same targeted response,” Wright said.

The initial Florida statewide dataset is the basis for the application for a COVID-19 Russell Sage Foundation grant. This second grant will fund the exploration of racial and socioeconomic disparities related to COVID-19 in the Southeastern United States and how those factors can impact economic stability for African Americans.

Wright teaches in the Master of Public Administration Program at Askew School of Public Administration and Policy. His work sits at the intersection of racism, policing, and protests.

Outside of his COVID-19 work his published and current projects include an examination of police policies and practices regarding the use of force, the implementation of body cameras programs by police departments, and the affect school resource officers can have on student performance.

About Dr. James Wright

James E. Wright II, Ph.D. is an Assistant Professor in the Askew School of Public Administration and Policy, where he teaches courses in the Master of Public Administration Program. Dr. Wright seeks to address how organizational behavior impacts goals and outcomes, primarily for people of color. Dr. Wright’s research projects focus on topics within the field of public administration, public policy, criminal justice and sociology. His current projects include examining police use of force policies and practices, the use and implementation of body-worn cameras by police departments, and the impact that school resource officers have on student performance. For more information, please visit

https://www.drjamesewright.com.

Share article on social media or email:

Rritual, Premium North American Brand in the Emerging Functional Mushroom Market Announces Dr. Mike Hart as President


Rritual Announces Dr. Mike Hart as President

“My belief is that mental fitness is a daily ritual, Rritual’s product portfolio and approach completely supports my current research and values as a plant-based practitioner,” said Dr. Mike Hart.

Rritual, the premium brand in the emerging functional mushroom market, announced today that Dr. Mike Hart has been named as the President of North America’s leading mushroom adaptogens company.

Dr. Hart has more than 6 years of experience in plant based therapy, including owning and operating his own family medicine clinic in London, Ontario, Canada where he regularly integrates plant-based wellness techniques, seeing optimal success with his patients in supporting them to treat common symptoms such as pain, inflammation, insomnia, depression and much more. His mission is to help his patients integrate plant-based therapies to lead the healthiest lifestyle possible.

Rritual, the rapidly growing North American leader in the emerging functional mushroom market is transforming the functional food industry with their Reishi, Chaga, Cordyceps, and Lion’s Mane mushroom focused super food product portfolio which currently includes elixirs, mixes and shots combined with synergistic adaptogenic herbs. Their data-backed, unique formulations for their premium, plant-based elixirs include key ingredients to help support cognitive function, stress relief, and boost immunity.

“Dr. Mike Hart is the perfect leader for Rritual,” said David Kerbel, Chief Executive Officer. “Dr. Hart’s extensive plant-based medicine background, business development skills, passion for health and wellness, and extensive trusted platform significantly strengthens our rapid expansion, brand presence and scalability in the emerging functional mushroom market,” Kerbel added.

“I am very excited to be joining the Rritual team,” said Dr. Mike Hart. “I believe Rritual has a great business model and, product portfolio in addition to a talented, and passionate management team that uniquely positions it for success in the emerging plant-based industry. Their mission to help people adapt to modern life and prove that mushrooms are one of the world’s greatest superfoods, is a perfect fit with my own wellness practices as a Physician, and personally as an individual who is passionate about mental and physical health.”

“My belief is that mental fitness is a daily ritual, and Rritual’s product portfolio and approach completely supports my current research and values as a seasoned, plant-based practitioner, having the tools and products available to individuals to help support their mental and physical fitness is of the utmost importance,” Hart added.

Currently one of the world’s foremost experts in plant-based medicine, In September of 2002, Dr. Hart began studying nutritional biochemistry at Memorial University and completed his degree in 2006. After completing his undergraduate degree he obtained his medical degree at Saba School of Medicine in the Netherlands Antilles from 2006-2010. In 2014, Dr. Hart became the first physician in London, Ontario, Canada to open a Cannabis Clinic. His passion for helping patients with wellness tools runs deep with having supported thousands of patients to live symptom-free and lead healthier lifestyles since he began practicing medicine. He is also the co-author of the Amazon Best Seller “Friendly Fire”: Why Vets Are Lighting Up and Ditching Pills to Treat PTSD.

About Rritual

Launched in 2020, Rritual is guided by a single purpose: to help each and everyone meet the demands of modern life with style and ease through mushroom adaptogens. Rritual makes premium plant-based elixir products in small batches featuring mindfully-selected medicinal mushrooms and adaptogenic herbs. To help support and achieve an optimal need-state, Rritual offers a range of products to fit every lifestyle. Rritual produces simple mushroom adaptogen products with limited, yet very purposeful and organic ingredients. Most of all, Rritual wants to help people adapt to the strain of modern life and prove that mushrooms truly are the world’s greatest superfoods. You can find out more about Rritual by visiting https://wearerritual.com/ or find them on Twitter, Instagram, LinkedIn, and Facebook.

About Dr. Mike Hart

Dr. Michael Hart, M.D, is one the world’s most foremost experts on plant based medicine. In 2014, Dr. Hart became the first physician in London, Ontario, Canada to open a Cannabis Clinic. In 2016 he founded Readytogo Medical Clinic, where he currently acts as the lead physician and medical director. He is also the co-author of the Amazon Best Seller “Friendly Fire”: Why Vets Are Lighting Up and Ditching Pills to Treat PTSD and the Candian Medical Ambassador for Athletes for CARE. His outspoken stance has landed him on a variety of media outlets, including an appearance on the Joe Rogan Experience Podcast which received over 3.2M views to date. You can find out more about Dr. Hart by visiting his website: https://mikehartmd.com/ or find him on Twitter, Instagram, LinkedIn, Facebook, YouTube.

For more Information, or press inquiries contact:

Jess Moran

Principal & Founder, JESSCO

jess@jessmco.com

519-494-5379

Share article on social media or email:



Radius Bank Announces Multiple New Hires Amid Continued Growth


News Image

Radius Bank, a forward-thinking digital bank, announced today it has hired three new team members within the Institutional Banking division to support recent growth and to better serve its clients. Radius’ newest team members, Tyler Mensick, John Relyea, and Joey Miranda, further strengthen the Bank’s offerings to businesses and labor unions both small and large nationwide.

Tyler Mensick, Vice President of Regional Sales and Relationship Manager for Escrow Sales, is primarily focused on business development and the acquisition of escrow deposits. He joins Radius from Opus Bank, where he spent eight years in various senior roles as the head of relationship management and deposit generation. During his time at Opus Bank, Mensick focused heavily on growing large portfolios of escrow deposits and developing strong, reciprocal relationships with multifamily and commercial real estate brokers, borrowers, lenders, and title representatives. He is based in Los Angeles, California and supports clients across the country for Radius.

John Relyea, Senior Vice President of Commercial API Banking, is tasked with driving the development and deployment of Radius’ strategy for API Banking that provides businesses with the convenience of using application programming interfaces (APIs) to send and receive payments and manage their cash from within their current operating systems, versus having to use the Bank’s online or mobile banking platform. Before joining Radius, Relyea was the Senior Vice President of Direct Lending at Security National Automotive Acceptance Company. Within his previous role, he had success in transforming go-to-market strategies, leading UX marketing and branding revamps, and managing cross-functional teams. With more than 25 years of experience, Relyea has built an expertise in crafting digital visions, defining strategies and cross-functional collaborations, and negotiating with stakeholders. He is based in Cleveland, Ohio.

Joey Miranda, Vice President of Cash Management Sales, is working directly with the Institutional Banking relationship team to provide subject matter expertise in cash management sales and deposit support. Miranda joins Radius from Santander Bank, where he spent the last five years in various senior roles including his most recent position as AVP Cash Management Sales Officer. He is based in Boston, Massachusetts.

“As we experience continued growth and seek to broaden our reach into new businesses and industries, it was essential that we expanded our workforce to better serve our clients,” said Phil Peters, Radius’ Executive Vice President / Chief Operating Officer. “Each of them brings a uniquely qualified background, and I look forward to seeing them utilize their expertise to help the Institutional Banking team exceed their goals in 2020.”

To learn more about Radius Bank, visit http://www.radiusbank.com or connect on Twitter, LinkedIn, Facebook, and Instagram.

About Radius Bank

With assets of approximately $1.5 billion, Radius Bank is a forward-thinking digital bank committed to providing a full complement of accounts and services to meet the banking needs of consumers and businesses nationwide. Radius provides the product depth of a national brand, the technology of a fintech, and the personalized attention typically reserved for a local bank to consumers, small and middle market businesses, unions, government entities and non-profit organizations. The Bank’s award-winning digital banking platform allows consumer clients to bank from anywhere with a computer or mobile device and provides convenient features such as check deposit, bill pay, card management, and a personal financial management dashboard. Business clients enjoy a wide array of award-winning deposit products, advanced treasury management services, and loan and payment solutions. In addition, Radius’ suite of open APIs delivers a robust banking-as-a-service (BaaS) platform for fintechs to quickly access core banking features and build best-in-class financial solutions. Radius specializes in partnering with forward-thinking fintechs to provide white-label deposit products, cards, digital onboarding, and account management. Radius Bank is a member of the Federal Deposit Insurance Corporation and is an Equal Housing/Equal Opportunity Lender. For further information, visit the Bank’s website at radiusbank.com, or follow the Bank on Twitter, LinkedIn, Facebook, and Instagram.

Share article on social media or email:



AGB Releases New Publication Outlining Best Practices for Higher Education Boards Overseeing Crisis Management


The Association of Governing Boards of Universities and Colleges (AGB), the premier organization representing higher education governance, today released a new publication, Crisis Leadership for Boards and Presidents: Anticipating, Managing, and Leading Beyond Pandemics, Disruptions, and Ethical Failures. This resource is intended to guide higher education boards as they anticipate, manage, and lead through and beyond difficult crises. As colleges and universities grapple with the COVID-19 pandemic, board members need strategic guidance to aid them not only in this unprecedented situation, but through future crises as well.

The book, written by AGB Senior Fellow Terrence MacTaggart, details how to anticipate a crisis; how to ask, “what if?” and prepare accordingly; how to diagnose an existing crisis; and how to develop an effective response. MacTaggart, a former chancellor of the Minnesota State University System and the University of Maine System, stated that “how a board and president envision the future in the midst of the crisis determines their fate afterwards. Combining realism with a willingness to change leads to far better outcomes than assuming a return to the ‘old normal.’”

The book also outlines three distinct types of crises, each requiring a different kind of response:

  • global catastrophes, such as the coronavirus pandemic and the 2008 recession
  • local emergencies, such as natural disasters and mass shootings
  • fiduciary crises, such as ethical violations, executive malfeasance, and admissions scandals

“Crises, by definition, are incredibly disruptive and radically affect the operations of a college, university, or system,” said MacTaggart. “While not every crisis can be prevented, each one must be managed adroitly. Working together, presidents and boards must take steps to ensure such events are not repeated. I hope this resource will help presidents and board members become more adept at leading their institutions beyond crises to a brighter future.”

Crisis Leadership for Boards and Presidents draws from real-world examples of major disruptions, distilling them into critical lessons that can be applied to many different scenarios. This resource also includes multiple checklists that presidents and boards can quickly use to assess gaps they may encounter when preparing for or facing a crisis. The book draws on the experience of effective leaders who faced major adversity and have enabled their institutions to become stronger and more resilient enterprises. These case studies demonstrate how a president and board, working together, can transform a crisis into an opportunity through strategy and partnership. Additionally, two appendices include hypothetical case studies with questions for boards, allowing readers to practice specific scenario planning and “what if” exercises.

“Given the number of crises that have made headlines, deeply affecting institutions and higher education as a whole, it’s evident that even the most prudent board can expect some kind of emergency to strike,” said Henry Stoever, AGB president and CEO. “AGB has long encouraged governing boards to be strategic partners with their presidents and management teams. Understanding how to approach a crisis is one major component to that end.”

A complimentary e-book version of Crisis Leadership for Boards and Presidents is available for AGB members at AGB.org/CrisisLeadership. It is also available for purchase in hard copy with a membership discount. Both the digital and print versions include tips for board members and presidents.

About AGB

The Association of Governing Boards of Universities and Colleges (AGB) is the premier membership organization that strengthens higher education governing boards and the strategic roles they serve within their organizations. Through our vast library of resources, educational events, and consulting services, and with nearly 100 years of experience, we empower 40,000 AGB members from more than 2,000 institutions and foundations to navigate complex issues, implement leading practices, streamline operations, and govern with confidence. AGB is the trusted resource for board members, chief executives, and key administrators on higher education governance and leadership.

Share article on social media or email:

Dental Professionals are at the Highest Risk of Contracting COVID-19


Anesthesia Progress volume 67 issue 1

Anesthesia Progress volume 67 issue 1

Of particular note was the splatter found behind the face shield and underneath the chin of the anesthesiologist, illustrating just how impactful a cough can be at releasing the SARS-CoV-2 virus.

Anesthesia Progress—Receiving dental care during the COVID-19 pandemic has been extremely challenging for patients and providers alike. The virus, which is primarily found in oral, nasal, and pharyngeal mucosa and in pulmonary secretions, is an air-borne contaminant and spreads through respiratory droplets, contact contamination, or by aerosols produced during aerosol-generating procedures (AGPs). Given the transmission type, four of the top five professions at the highest risk for the contracting the virus are within the dental field. It is of the upmost importance that appropriate protective measures are put into place before routine dental care can resume as normal.

Researchers from the University of Toronto, University of Vancouver, and private practice in British Columbia published a study in the current issue of Anesthesia Progress that examined the extent of splatter produced during an AGP or coughing while receiving dental care.

To simulate a dental procedure and examine the extent of splatter, the researchers used a dental mannequin fitted with a set of model teeth coated in Glo Germ™, which appears blue under an ultraviolet (UV) light. While wearing short-sleeved scrubs, goggles, a surgical mask, and gloves, a dentist and dental hygienist performed three different dental procedures on the mannequin using a high-speed handpiece, an ultrasonic scaler, and an air-water syringe; all three were done with continuous use of high-volume suction. To simulate a cough during a procedure, a ventilator was equipped with and programmed to release Glo Germ™ during the procedure. During this simulation a dentist anesthesiologist was introduced wearing the same personal protective equipment (PPE) as the dentist and hygienist, with the addition of a face shield. After each procedure or cough, the participants were taken to a dark room where UV light was used to examine splatter patterns and photographs were taken and analyzed to document the extent of the splatter.

The researchers found that after each AGP was performed, both the dentist and hygienist had splatter on their face, body, arms, and legs. The simulated cough showed an increased amount of splatter produced, and, in addition to their face, body, arms, and legs, the dentist and hygienist had splatter on the crown of their head, back, and shoes. The anesthesiologist had a significant amount of splatter on every surface of the body, except for the back and shoes. Of particular note was the splatter found behind the face shield and underneath the chin of the anesthesiologist, illustrating just how impactful a cough can be at releasing the SARS-CoV-2 virus.

The researchers conclude that in addition to eye protection, masks, and gloves, dental professionals should also wear face shields, bouffant/surgical caps, and shoe coverings to fully protect themselves from the virus. This full set of PPE should also be changed between patients to avoid cross-contamination of the patients or staff during procedures that generate AGPs.

Full text of the article, “Aerosol Generating Procedures and Simulated Cough in Dental Anesthesia,” Anesthesia Progress, is now available here.

###

About Anesthesia Progress

Anesthesia Progress is the official publication of the American Dental Society of Anesthesiology (ADSA). The quarterly journal is dedicated to providing a better understanding of the advances being made in the science of pain and anxiety control in dentistry. The journal invites submissions of review articles, reports on clinical techniques, case reports, and conference summaries. To learn more about the ADSA, visit: http://www.adsahome.org/.

Share article on social media or email:

Draper Demonstrates Miniature Organ Models Can Play Key Role in COVID-19 Drug Development


PREDICT96 is an organ-on-a-chip device seamlessly configured into an industry-standard multiwell cell culture plate.

As the global pandemic of COVID-19 continues to grow, our system has the potential to quickly evaluate antiviral and repurposed drugs to help combat this devastating disease. – Ashley Gard, Senior Member of the Technical Staff, Draper

Draper today announced the release of a new scientific article that describes how the company’s technology can be used to test an in vitro human lung model to investigate responses following infection with COVID-19 and influenza. The study was part of a collaboration between Draper and the University of Massachusetts Medical School. The manuscript, titled “High-Throughput Human Primary Cell-Based Airway Model for Evaluating Influenza, Coronavirus, or other Respiratory Viruses in vitro,” was posted in bioRxiv.

Several preclinical research tools are available to model respiratory infections, but due to the complexity of the human lung and requirements to accurately model host-virus interactions, these models provide a poor correlation as a basis for guiding clinical strategy. As many scientists are asking for models with stronger in vitro-in vivo correlation, the scientific community begins to turn more towards using organ-on-a-chip systems as a cost-effective and more accurate way to develop therapies.

Draper, in collaboration with UMass Medical School, describe an in vitro, microfluidic system containing functioning patient-derived human airway cells, which mature into human lung tissue that researchers monitored using integrated sensing and studied following controlled exposure to infectious respiratory pathogens. The PREDICT96 platform allows scientists to accurately mimic the structure and function of human lung tissues derived from donors with different patient profiles and sustain human tissue organ models for several weeks of automated testing.

“One of the greatest barriers to the development of effective therapeutic agents to treat influenza, coronaviruses and many other infections of the respiratory tract is the absence of a robust preclinical model. As the global pandemic of COVID-19 continues to grow, our system has the potential to quickly evaluate antiviral and repurposed drugs to help combat this devastating disease,” said Ashley Gard, Senior Member of the Technical Staff at Draper.

Current preclinical models typically rely on high-throughput, low-fidelity in vitro screening with cell lines or low-throughput animal models that often provide a poor correlation to human clinical responses. Emerging organ-on-chip models have the potential to overcome these limitations, but are often designed for research environments and are often incompatible with workflows and standard instrumentation in pharmaceutical laboratories.

In contrast, PREDICT96 is an organ-on-a-chip device seamlessly configured into an industry-standard multiwell cell culture plate, comprising 96 individual co-culture devices and a perfusion system driven by 192 microfluidic pumps integrated into the plate lid. Pairs of microchannels within each device, each less than a millimeter in diameter, are separated by a biomimetic semi-permeable membrane lined with human cells and arranged in complex configurations to support growth of human tissue. The device enables researchers to grow 96 human lung tissues at once and conduct 96 simultaneous experiments in order to evaluate different respiratory viruses, viral doses, viral strains and tissue from unique donors.

In the study, researchers evaluated the lung model’s responses to influenza A virus (IAV) and coronavirus (HCoV-NL63) and observed the behavior of airway cells in response to different therapeutic drug regimens. Results indicate that PREDICT96 can be used to model the human lung and its response to IAV and coronavirus infections, and could potentially be used to screen the efficacy of candidate therapeutics in a clinically relevant manner.     

“The most striking features of our organ-on-a-chip is that it captures different reactions to respiratory viral infection by influenza and coronavirus, as well as detected expressions of ACE2 and TMPRSS2,” said Joe Charest, Ph.D., Head of Strategy and Business Development, Pharmaceutical R&D Technologies at Draper. The ACE2 receptor and TMPRSS2 protein play key roles in COVID-19 infections, and their presence is critical to the ability to model the infection process. Draper has expanded use of PREDICT96 beyond testing drug interactions with liver, kidney, vascular, gum and gastrointestinal tissue models to the new application for COVID-19, Charest added.

Funding was provided by Draper for the coronavirus research and by Defense Advanced Research Projects Agency (DARPA) for the influenza A virus research under its PREPARE program. Last year Draper and UMass Medical School, while working on the PREPARE program, announced the first instance of a dynamic air-liquid interface model using patient-derived cells for influenza testing.

Dr. Robert W. Finberg, an investigator on the team and chair of Medicine at UMass Medical School and UMass Memorial Medical Center, said COVID-19 is a natural extension of the PREPARE research. “Several of us working primarily on influenza are very excited about working on this new virus and finding different ways to prevent the disease it causes,” he said.

To read the full manuscript, please visit https://www.biorxiv.org/content/10.1101/2020.05.23.112797v1

Share article on social media or email: